Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea

NCT02205346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2018-02-06

No results posted yet for this study

Summary

Investigate urinary leukotriene E4 levels and determine if there is a correlation with severity of obstructive sleep apnea. The investigators then would like to determine a threshold level which could then be used for confirmation of diagnosis of obstructive sleep apnea (OSA).

Conditions

Sponsors & Collaborators

  • Medarva

    collaborator UNKNOWN
  • Eastern Virginia Medical School

    lead OTHER

Principal Investigators

  • Cristina Baldassari, MD · EVMS

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-06-30
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02205346 on ClinicalTrials.gov